科研动态PubMed 摘要

[KASID指南:炎症性肠病的诊断与监测(2026年版)]

PubMed 白名单日捞 · 2026-01-01

完整摘要 · 中文译文

炎症性肠病(IBD)以异质性的疾病表现和临床病程为特征。准确的诊断和适当的疾病监测在改善长期预后方面发挥着重要作用,其途径包括防止误诊和不必要的治疗;实现疾病进展、治疗失败和疾病相关并发症的早期发现;以及促进治疗策略的及时调整。韩国肠道疾病研究协会(KASID)制定了反映韩国临床环境的成人IBD诊断与监测指南,以支持临床决策并提高患者护理质量。为制定这些指南,研究团队对现有的国际临床实践指南和专家共识声明进行了全面回顾,并结合了与每个临床主题相关的最新证据。最终建议通过采用改良德尔菲法的专家共识程序确定。这些指南涵盖了IBD诊断与监测中的主要临床领域,包括初始诊断和基线评估、疾病范围与活动性评估、溃疡性结肠炎和克罗恩病的疾病监测、营养评估以及结直肠癌监测。这些指南旨在支持个体化临床判断,应灵活应用,不仅需要考虑个体患者特征和临床情况,还需考虑可用资源、诊断和监测手段的可及性、法规要求以及患者偏好。 以及报销政策。

完整摘要 · 英文原文

Inflammatory bowel disease (IBD) is characterized by heterogeneous disease presentations and clinical courses. Accurate diagnosis and appropriate disease monitoring play an important role in improving long-term outcomes by preventing misdiagnosis and unnecessary treatment; enabling early detection of disease progression, treatment failure, and disease-related complications; and facilitating timely adjustment of treatment strategies. The Korean Association for the Study of Intestinal Diseases (KASID) developed guidelines for the diagnosis and monitoring of IBD in adults, reflecting the Korean clinical setting, to support clinical decision-making and improve the quality of patient care. To develop these guidelines, existing international clinical practice guidelines and expert consensus statements were comprehensively reviewed, along with updated evidence relevant to each clinical topic. Final recommendations were established through expert consensus using a modified Delphi process. These guidelines address major clinical areas in the diagnosis and monitoring of IBD, including initial diagnosis and baseline assessment, assessment of disease extent and activity, disease monitoring in ulcerative colitis and Crohn's disease, nutritional assessment, and colorectal cancer surveillance. These guidelines are intended to support individualized clinical judgment and should be applied flexibly, taking into account not only individual patient characteristics and clinical circumstances but also available resources, access to diagnostic and monitoring modalities, regulatory requirements, and reimbursement policies.

English
[KASID Guidelines for Diagnosis and Monitoring of Inflammatory Bowel Disease: 2026].
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界